A Randomized Trial of Initiation of Chronic Noninvasive Mechanical Ventilation at Home vs In-Hospital in Patients With Neuromuscular Disease and Thoracic Cage Disorder The Dutch Homerun Trial

Ries J. M. van den Biggelaar*, Anda Hazenberg, Nicolle A. M. Cobben, Michael A. Gaytant, Karin M. Vermeulen, Peter J. Wijkstra

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)

Abstract

BACKGROUND: There is an increasing demand for home mechanical ventilation (HMV) in patients with chronic respiratory insufficiency. At present, noninvasive ventilation is exclusively initiated in a clinical setting at all four centers for HMV in the Netherlands. In addition to its high societal costs and patient discomfort, commencing HMV is often delayed because of a lack of hospital bed capacity.

RESEARCH QUESTION: Is HMV initiation at home, using a telemonitoring approach, noninferior to in-hospital initiation in a nationwide study?

STUDY DESIGN AND METHODS: We conducted a nationwide, randomized controlled non-inferiority trial, in which every HMV center recruited 24 patients (home [n = 12] vs hospital [n = 12] ) with a neuromuscular disease or thoracic cage disorder, all with an indication to start HMV. Change in arterial CO2 (PaCO2) over a 6-month period was considered the primary outcome, and quality of life and costs were assessed as secondary outcomes.

RESULTS: A total of 96 patients were randomized, most of them diagnosed with neuromuscular disease. We found a significant improvement in PaCO2 within both groups (home: from 6.1 to 5.6 kPa [P <.01]; hospital: from 6.3 to 5.6 kPa [P <.01]), with no significant differences between groups. Health-related quality of life showed significant improvement on various subscales; however, no significant differences were observed between the home and hospital groups. From a societal perspective, a cost reduction of more than (sic)3,200 ((sic)3,793) per patient was evident in the home group.

INTERPRETATION: This nationwide, multicenter study shows that HMV initiation at home is noninferior to hospital initiation, as it shows the same improvement in gas exchange and health-related quality of life. In fact, from a patient's perspective, it might even be a more attractive approach. In addition, starting at home saves over (sic)3,200 ($3,793) per patient over a 6-month period.

Original languageEnglish
Pages (from-to)2493-2501
Number of pages9
JournalChest
Volume158
Issue number6
DOIs
Publication statusPublished - Dec 2020

Keywords

  • neuromuscular disease
  • noninvasive ventilation
  • telemedicine
  • thoracic cage abnormality
  • QUALITY-OF-LIFE

Cite this